Hasegawa Hirotaka, Shin Masahiro, Kawagishi Jun, Jokura Hidefumi, Hasegawa Toshinori, Kato Takenori, Kawashima Mariko, Shinya Yuki, Kenai Hiroyuki, Kawabe Takuya, Sato Manabu, Serizawa Toru, Nagano Osamu, Aoyagi Kyoko, Kondoh Takeshi, Yamamoto Masaaki, Onoue Shinji, Nakazaki Kiyoshi, Iwai Yoshiyasu, Yamanaka Kazuhiro, Hasegawa Seiko, Kashiwabara Kosuke, Saito Nobuhito
Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
Jiro Suzuki Memorial Gamma House, Furukawa Seiryo Hospital, Osaki, Japan.
J Stroke. 2022 May;24(2):278-287. doi: 10.5853/jos.2021.03594. Epub 2022 May 31.
To assess the long-term outcomes of intracranial dural arteriovenous fistula (DAVF) treated with stereotactic radiosurgery (SRS) alone or embolization and SRS (Emb-SRS) and to develop a grading system for predicting DAVF obliteration.
This multi-institutional retrospective study included 200 patients with DAVF treated with SRS or Emb-SRS. We investigated the long-term obliteration rate and obliteration-associated factors. We developed a new grading system to estimate the obliteration rate. Additionally, we compared the outcomes of SRS and Emb-SRS by using propensity score matching.
The 3- and 4-year obliteration rates were 66.3% and 78.8%, respectively. The post-SRS hemorrhage rate was 2%. In the matched cohort, the SRS and Emb-SRS groups did not differ in the rates of obliteration (P=0.54) or post-SRS hemorrhage (P=0.50). In multivariable analysis, DAVF location and cortical venous reflux (CVR) were independently associated with obliteration. The new grading system assigned 2, 1, and 0 points to DAVFs in the anterior skull base or middle fossa, DAVFs with CVR or DAVFs in the superior sagittal sinus or tentorium, and DAVFs without these factors, respectively. Using the total points, patients were stratified into the highest (0 points), intermediate (1 point), or lowest (≥2 points) obliteration rate groups that exhibited 4-year obliteration rates of 94.4%, 71.3%, and 60.4%, respectively (P<0.01).
SRS-based therapy achieved DAVF obliteration in more than three-quarters of the patients at 4 years of age. Our grading system can stratify the obliteration rate and may guide physicians in treatment selection.
评估单纯立体定向放射外科治疗(SRS)或栓塞联合SRS(Emb-SRS)治疗颅内硬脑膜动静脉瘘(DAVF)的长期疗效,并建立一个预测DAVF闭塞的分级系统。
这项多机构回顾性研究纳入了200例接受SRS或Emb-SRS治疗的DAVF患者。我们调查了长期闭塞率及与闭塞相关的因素。我们建立了一个新的分级系统来估计闭塞率。此外,我们通过倾向得分匹配比较了SRS和Emb-SRS的疗效。
3年和4年闭塞率分别为66.3%和78.8%。SRS后出血率为2%。在匹配队列中,SRS组和Emb-SRS组在闭塞率(P=0.54)或SRS后出血率(P=0.50)方面无差异。在多变量分析中,DAVF的位置和皮质静脉回流(CVR)与闭塞独立相关。新的分级系统分别给予前颅底或中颅窝的DAVF、伴有CVR的DAVF或上矢状窦或小脑幕的DAVF、以及无这些因素的DAVF 2分、1分和0分。根据总分,患者被分为闭塞率最高(0分)、中等(1分)或最低(≥2分)组,其4年闭塞率分别为94.4%、71.3%和60.4%(P<0.01)。
以SRS为基础的治疗在4年时使超过四分之三的患者实现了DAVF闭塞。我们的分级系统可以对闭塞率进行分层,并可能指导医生进行治疗选择。